Keunchil Park

32PUBLICATIONS
136CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Community and primary careAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jan 06, 2025
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions.

Yibei Wang, Mohammed Safi, Fred R Hirsch

|Jun 03, 2024
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer.

Maurice Pérol, Benjamin J Solomon, Koichi Goto

|Jan 22, 2024
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722.

Tony Mok, Kazuhiko Nakagawa, Keunchil Park

|Oct 16, 2023
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.

Sehhoon Park, Yu Jung Kim, Young Joo Min

|Sep 14, 2023
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial.

Byoung Chul Cho, Dong-Wan Kim, Alexander I Spira

|Mar 22, 2023
Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers.

Yuan Yuan, Young Seok Ju, Youngwook Kim

Pageof 6

Frequent Collaborators

7 joint publications

Hyun-Ae Jung

6 joint publications

Se-Hoon Lee

4 joint publications

Yuan Yuan

4 joint publications

Young Seok Ju